Despite considerable research connecting cellular metabolism with differentiation decisions, the underlying mechanisms that translate metabolite-sensitive activities into unique gene programs are still unclear.
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Metabolic states dynamically change during cellular differentiation, but it is currently unclear how changes in metabolism mechanistically regulate differentiation gene programs. Chisolm et al. define a mechanism by which CTCF translates IL-2-and aKG-sensitive metabolic events into context-dependent differentiation gene programs.
INTRODUCTION
Cellular metabolism is closely coupled to differentiation gene programs in many developmental systems (Pearce et al., 2013; Ryall et al., 2015) . In part, this is due to a similar complement of transcription factors playing dual roles regulating both the gene expression programs associated with differentiation and specific metabolic pathways (Oestreich et al., 2014; Polo et al., 2012) . In T cells, T-cell-receptor (TCR)-and interleukin-2 (IL-2)-sensitive transcription factors coordinate the programming of metabolic states with the effector and memory gene programs (Chisolm and Weinmann, 2015) . In particular, the induction of glycolysis, glutaminolysis, and the lipid biosynthesis pathway are required for effector T cell differentiation (Pearce et al., 2013; Wang et al., 2011) . Inhibition of these metabolic states, whether in dysregulated environmental states, through genetic means, or with metabolic inhibitors, results in altered effector T cell differentiation Doedens et al., 2013; Ho et al., 2015; Sukumar et al., 2013) . To date, the mechanisms by which metabolic states actively contribute to the regulation of T cell differentiation gene programs are unclear.
Research in embryonic stem (ES) cells has provided insight into how metabolism influences epigenetic states and differentiation gene programs. Metabolic reprogramming in ES cells plays a role in broadly regulating epigenetic states through the ability of metabolites to serve as donors and substrates for DNA and histone modifications, as well as co-factors for epigenetic-modifying complexes (Ryall et al., 2015) . For example, threonine metabolism influences ES cell differentiation in part by modulating the metabolites S-adenosylmethionine (SAM) and acetylcoenzyme A (acetyl-CoA) to broadly influence the state of histone modifications in the cell (Shyh-Chang et al., 2013) . Glucose metabolism mediated through the glycolysis pathway can change acetyl-CoA levels and bulk histone acetylation to impact ES cell differentiation potential (Moussaieff et al., 2015) . Recently, this activity was observed in T cells, as well (Peng et al., 2016) . Another example is related to glutamine (Gln) uptake, which in part regulates intracellular alpha-ketoglutarate (aKG) levels (Carey et al., 2015) . The accumulation of intracellular aKG influences the differentiation potential of ES cells, with some of its activity related to the role for aKG as a required cofactor for the Jumonji C family of histone demethylases, as well as for the ten eleven translocation (TET) family of DNA-dioxygenases, which can cause broad changes in the state of histone and DNA methylation in the cell (Su et al., 2016; Tahiliani et al., 2009) . A major gap in our current knowledge is how these broad epigenetic events are precisely translated into specific differentiation gene programs.
CCCTC-binding factor (CTCF) is a DNA-binding zinc-finger transcription factor that plays a role in spatially organizing the genome to promote the precise regulation of developmental processes and gene programs (Benner et al., 2015; Bonora et al., 2014; Ong and Corces, 2014) . The methylation state of select CTCF DNA binding sites influences the ability of CTCF to bind to genomic elements and is thought to be important for defining cell-type-and context-specific gene programs (Teif et al., 2014) . In addition, CTCF association with select genomic regions is dysregulated in glioma cells with mutations in isocitrate dehydrogenase (IDH), suggesting that aberrant metabolism disrupts the normal activity of CTCF (Flavahan et al., 2016) . This raises the question of whether CTCF might be sensitive to natural changes in metabolic states that occur during cellular development and serve to integrate metabolic information into differential gene programs.
In this study, we found that metabolic perturbations mediated through Gln and aKG influenced aspects of the IL-2-sensitive effector gene program in CD4 + T helper 1 (Th1) and CD8 + T cytotoxic 1 (Tc1) cells. At least part of the role for aKG was related to histone H3 lysine 27 trimethylation (H3K27me3) and DNAmethylation states. Mechanistically, we defined that IL-2-sensitive changes in metabolism mediated through aKG promoted CTCF association with a select subset of CTCF sites, and this impacted genome topology. We also found that IL-2-and aKG-sensitive events were differentially interpreted based in part on the surrounding epigenetic landscape. Collectively, these data suggest that changes in metabolism play a role in regulating cellular differentiation programs by altering CTCFbinding patterns and genome interactions, but that additional context-dependent activities influence the functional impact for these events.
RESULTS
aKG Influences the Expression of IL-2-Sensitive Genes in CD4 + Th1 and CD8 + Tc1 Cells To define the mechanisms by which IL-2-sensitive changes in metabolism contribute to T cell differentiation gene programs, we utilized an experimental system in which primary CD4 + or CD8 + T cells polarized in type 1 conditions were maintained in either high or low environmental concentrations of IL-2 (Figure S1A) (Oestreich et al., 2012; Oestreich et al., 2014) . The strength of IL-2 signaling can influence the gene expression programming between the effector and memory (or T follicular helper [Tfh] ) differentiation signatures in T cells (BallesterosTato et al., 2012; Kalia et al., 2010; Oestreich et al., 2012; Pipkin et al., 2010) . We recapitulated these results in RNA-sequencing (RNA-seq) and gene set enrichment analyses (GSEA), which demonstrated that high environmental IL-2 concentrations (high IL-2) promoted a gene signature similar to effector T cells formed during a natural type I immune response in vivo (Figure S1C) (Luckey et al., 2006; Wherry et al., 2007) . In contrast, genes in the memory signature, as well as the Tfh signature, were enriched in cells maintained in low environmental IL-2 concentrations (low IL-2). In addition, metabolites in the glycolysis pathway, as well as in glutaminolysis, such as aKG, accumulate in effector T cells and with high IL-2 conditions (Gerriets et al., 2015; van der Windt et al., 2013; Verbist et al., 2016; Wang et al., 2011 ) ( Figure S1D ). Taken together, this represents a tractable primary cell setting to define the mechanisms by which metabolic events influence T cell differentiation gene programs.
To address whether the IL-2-induced accumulation of aKG contributes to T cell differentiation gene programming, we added cell permeable aKG (dimethyl-alpha-ketoglutarate, referred to as aKG) (Carey et al., 2015) to primary CD4 + or CD8 + T cells polarized in type I conditions and maintained in low environmental IL-2 concentrations ( Figure S1A ). If aKG plays an important role in promoting aspects of the IL-2-dependent effector gene program, the addition of aKG to CD4 + Th1 or CD8 + Tc1 cells maintained in low IL-2 concentrations would promote the expression of the effector program similar to that observed in high IL-2 conditions. We first performed quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analyses to assess the expression of select IL-2-sensitive effector or memory genes in the Th1 or Tc1 cells maintained in high IL-2, low IL-2, or low IL-2 with aKG. Genes associated with the effector program, including Ifng, Cxcr4, and Prdm1, as well as genes associated with the glycolysis pathway, including Hk2 and Slc2a1, were induced in both high IL-2 as well as low IL-2 with aKG in comparison to the low IL-2 condition alone ( Figures 1A and 1B ). In contrast, select genes associated with memory or Tfh potential, such as Tcf7, were inhibited by the addition of aKG to the low IL-2 condition similar to the high IL-2 condition (Figures 1A and 1B) . As a control, the addition of cell permeable succinate had little to no effect on the expression of these genes in CD4 + Th1 cells ( Figure S1E ).
We next addressed whether the aKG-sensitive changes in gene expression cause a functional consequence on protein expression. To assess this, we monitored protein expression encoded by IL-2-and aKG-sensitive genes from primary CD4 + T cells polarized in Th1 conditions and maintained in high IL-2, low IL-2, or low IL-2 with aKG. Similar to the gene expression data, TCF1 (encoded by the Tcf7 gene) and chemokine receptor CXCR3 protein expression were inhibited by IL-2-and aKGsensitive activities, whereas interferon g (IFNg) production and hexokinase 2 (HK2) expression were enhanced ( Figures 1C-1F ). Therefore, protein and gene expression patterns were similar, indicating that aKG-sensitive changes in gene expression can be translated into functional changes at the protein level.
aKG Induces Aspects of the IL-2-Sensitive Effector Gene Program in CD4 + Th1 and CD8 + Tc1 Cells
We next conducted RNA-seq analyses on CD4 + Th1 or CD8 + Tc1 cells maintained in high IL-2, low IL-2, or low IL-2 with aKG to define the composition of the IL-2-sensitive gene program that is impacted by metabolic changes related to aKG. As a control, the RNA-seq experiments showed similar trends in the expression of the select genes that were monitored by qRT-PCR ( Figures 1A,  1B , S2A, and S2B). Using a two-fold threshold for differential gene expression, roughly 28%-35% of the gene program that was induced in high IL-2 relative to low IL-2 conditions was also induced by the addition of aKG to the low IL-2 condition in CD4 + Th1 and CD8 + Tc1 cells, respectively (Figures 2A and 2B ). In contrast, aKG inhibited approximately 8%-14% of the genes that were more highly expressed in low IL-2 relative to high IL-2 conditions. These data suggest that aKG-sensitive events play a role in both the induction and inhibition of the IL-2-sensitive gene program in CD4 + Th1 and CD8 + Tc1 cells, with aKG-sensitive activities having a greater role in promoting IL-2-inducible events. Additionally, nearly 80% of the genes that were aKG-sensitive were also IL-2-sensitive (Figures 2A and 2B ). This suggests that a substantial portion of the aKG-sensitive program in CD4 + Th1 and CD8 + Tc1 cells relates to the IL-2-sensitive program.
We next performed GSEA on the genes that were induced by the addition of aKG to low IL-2 in comparison to the low IL-2 condition alone. The genes induced by aKG were enriched for pathways associated with effector potential, antigen response, (legend continued on next page) IL-2-STAT5 signaling, and glycolysis, indicating that genes in these pathways were sensitive to positive feedback regulation mediated by IL-2-sensitive changes in metabolism ( Figure 2C , 2D, and S2C) (Goldrath et al., 2004; Luckey et al., 2006) . The number of genes induced by aKG in these pathways was approximately 30%-50% or more of the genes that were induced in the high IL-2 condition in comparison to low IL-2. Of note, not all genes that were induced by aKG in the low IL-2 condition were expressed to the same magnitude as compared to the high IL-2 condition. In addition, not all pathways, including the cell cycle G2M checkpoint, that were induced by strong IL-2 signaling were also regulated by aKG (Figure 1 , 2, and S2). There was also some divergence in the identity of the genes with defined effector functions and some variability in the magnitude for the aKG-sensitive induction of genes between CD4 + Th1 and CD8 + Tc1 cells (Figure 1 , 2, and S2). Taken together, these data suggest that IL-2-sensitive metabolic changes related to aKG play a conserved role in the activation of a subset of genes associated with aspects of the IL-2-sensitive effector T cell differentiation program in type 1 conditions. However, additional events related to the traditional IL-2-signaling pathway are also required for the full induction of this program, and aspects of the cell type background influence how aKG-sensitive events are interpreted. GSEA indicated that genes in the G2M checkpoint pathway were induced by IL-2-sensitve, but not aKG-sensitive, events. Therefore, we next compared the cellular proliferation rates for the CD4 + T cells polarized in Th1 conditions and maintained in high IL-2, low IL-2, or low IL-2 with aKG. Th1 cells maintained in high IL-2 conditions proliferated more robustly than cells maintained in either low IL-2 or low IL-2 with aKG ( Figure 2E ). Thus, consistent with the gene-expression data, aKG-sensitive activities were not sufficient to promote the IL-2-sensitive enhancement of cellular proliferation. Additionally, the size of the cell as measured by forward and side scatter was more similar between high IL-2 and low IL-2 with aKG in comparison to the low IL-2 condition ( Figure S3A ). Together, these data suggest that aKG-sensitive activities are sufficient to promote the events that lead to an increase in cell size, but this is not translated into more robust proliferative capacity. These data also indicated that the similarities in IL-2-and aKG-sensitive gene-expression patterns were not merely caused by similarities in proliferation rates.
Gln-and aKG-Sensitive Events in Part Regulate the IL-2-Sensitive Gene Program Gln can be converted into aKG through the glutaminolysis pathway, which is important for the regulation of aKG-sensitive ES cell differentiation gene programs (Carey et al., 2015) . In T cells, Gln transporter expression and glutaminolysis is required to promote aspects of effector T cell functions (MacIver et al., 2013; Nakaya et al., 2014; Pollizzi et al., 2016; Verbist et al., 2016) . Together, this led us to ask whether limiting Gln influences the IL-2-sensitive gene programs that are regulated by aKG-sensitive events.
To address this question, we performed experiments limiting Gln activity during CD4
+ Th1 cell differentiation and tested the ability of aKG to rescue Gln-sensitive gene expression. As one approach, primary CD4 + T cells polarized in Th1 conditions were maintained in high environmental IL-2 and either left untreated or were treated with the Gln analog 6-diazo-5-oxo-L-norleucine (DON) to inhibit glutaminolysis. As another approach, cells were maintained in the presence or absence of Gln. Both DON treatment and culturing cells in the absence of Gln inhibited the IL-2-sensitive expression of several genes associated with the effector program, including Prdm1, Hlx, and genes in the glycolysis pathway, while it modestly enhanced expression of Tcf7, a gene related to the Tfh or memory program ( Figure 2F , S3B, and S3C). The addition of aKG to Th1 cells maintained without Gln in high IL-2 conditions, or those treated with DON, rescued the Gln-sensitive expression of these genes ( Figure 2F , S3B, and S3C).
The gene expression experiments were consistent with previous studies that indicated Gln is important for promoting the T effector (Teff) cell differentiation program at the expense of alternative programs such as the Tfh cell program (Nakaya et al., 2014 Figure 2G ). However, the frequencies ( Figure 2H ) and numbers ( Figure 2I To define the gene program impacted by these activities, we performed an RNA-seq analysis on CD4 + T cells polarizing in Th1 conditions cultured either with or without Gln at the time of initial TCR activation. Following TCR stimulation, the cells were then split and maintained in high-IL-2 or low-IL-2 concentrations in either the presence or absence of Gln ( Figure S1B ). Gln mechanistically plays many roles in regulating signaling events, mechanistic target of rapamycin (mTOR), and post-translational events such as O-GlcNAcylation (Nakaya et al., 2014; Swamy et al., 2016) . To focus our analysis on the Gln-sensitive activities that are related to aKG, we also examined cells cultured with or without aKG addition. As another control, we examined by qRT-PCR a subset of genes in the presence of rapamycin (Figure S4G) . The RNA-seq analysis identified a subset of approximately 204 genes that were IL-2-, Gln-, and aKG-sensitive, with the vast majority of genes (171) induced by IL-2-, Gln-, and aKG-sensitive events ( Figure 2L ). Genes with functions more specifically associated with T cell differentiation programming were often stably inhibited throughout the differentiation program when Gln was absent at the time of TCR activation. This suggests that a type of epigenetic process that involves Gln-and aKG-sensitive events influences key aspects of the T cell differentiation program. In contrast, the expression of genes in the glycolysis pathway appeared to be more transiently sensitive to Gln and aKG activities, indicating that some genes were impacted by the current state of Gln in the environment ( Figure 2L ).
IL-2-and aKG-Sensitive Events Influence H3K27me3
States in CD4 + Th1 Cells We next wanted to interrogate the mechanisms by which aKG influences the regulation of the IL-2-sensitive gene programs in CD4 + Th1 cells. aKG is a required cofactor for DNA and histone demethylase complexes (Su et al., 2016) . We found that genes induced by aKG in CD4 + Th1 and CD8 + Tc1 cells were significantly enriched for pathways related to H3K27me3 and DNA methylation states in diverse cell types ( Figure 3A) . Genes induced in high IL-2 relative to low IL-2 conditions were also highly enriched in the same pathway datasets. These pathway analyses allude to a role for aKG in regulating the IL-2-sensitive differentiation program through alteration of H3K27me3 and DNA methylation states. To start to address this possibility, we performed a chromatin immunoprecipitation-sequencing (ChIP-seq) analysis examining H3K27me3 states in CD4 + Th1 cells maintained in high IL-2, low IL-2, or low IL-2 with aKG. There was a modest global decrease in H3K27me3 ChIP enrichment throughout the genome in the high IL-2 compared to low IL-2 conditions, suggesting that events downstream of IL-2-signaling generally favor lower H3K27me3 levels ( Figure 3B ). The addition of aKG to the low IL-2 condition caused a global decrease in H3K27me3 ChIP enrichment that was modestly more robust than the decrease observed in the high IL-2 condition ( Figure 3B ). Previous studies have shown a role for Jmjd3, an H3K27me3-demethylase, in T cell and Th1 differentiation states (Manna et al., 2015; Miller et al., 2008) . Thus, these data suggest that the IL-2-sensitive changes in H3K27me3 might be functionally regulated by aKGsensitive events impacting H3K27me3-demethylase activity.
To address this, we performed experiments limiting H3K27me3-demethylase activity in high IL-2 conditions. Primary CD4 + T cells polarized in Th1 conditions were maintained in high IL-2 concentrations either with or without GSK-J4, an H3K27-demethylase inhibitor. For comparison, cells were maintained in low IL-2 concentrations or high IL-2 with DON to limit aKG activity. For these experiments, we examined the expression of IL-2-and aKG-sensitive genes that were associated with strong decreases in aKG-sensitive H3K27me3 peaks. Genes analyzed with this criteria, including Prdm1 and P4ha2, were inhibited by the addition of GSK-J4 to the high IL-2 condition (Figures 3C and S3D). As a negative control, Hlx, a gene that was induced by IL-2-and aKG-sensitive activities, but was not associated with aKG-sensitive H3K27me3 peaks in the ChIP-seq analysis, was not impacted by GSK-J4 ( Figure 3C ). These data suggest that the role for aKG as a cofactor in H3K27-demethylase complex activity is important for a subset of IL-2-and aKG-sensitive target gene expression.
DNA Methylation States Play a Role in IL-2-and aKG-Sensitive Gene Expression
We next wanted to assess whether the state of DNA methylation might contribute to the expression of the IL-2-sensitive genes that are also sensitive to aKG. To begin to address this question, we examined the role for TET2, a DNA-demethylase that requires aKG as a cofactor for its activity, in regulating IL-2-and aKGsensitive genes. We transfected primary CD4 + T cells polarized in Th1 conditions with either a control small interfering RNA (siRNA) or an siRNA to Tet2 and maintained the cells in high environmental IL-2 concentrations. The qRT-PCR analyses demonstrated that several IL-2-and aKG-sensitive target genes had decreased expression with Tet2 knockdown ( Figure S3E ). To further address whether genes with IL-2-and aKG-sensitive expression might be influenced by DNA methylation states, we utilized the DNA methyltransferase inhibitor 5-azacytidine (5-aza) to inhibit DNA methylation events. CD4 + Th1 cells maintained in low IL-2 concentrations were either left untreated or were treated with 5-aza. In the qRT-PCR analyses, IL-2-and aKG-sensitive genes, including Hk2, Ifng, and Hlx, were induced by 5-aza treatment to a similar extent as aKG treatment (Figure 3D ). The inhibition of DNA methylation diminished the expression of genes such as Klf2 and Sell (encodes CD62L) to a similar extent that aKG inhibited their expression. It is also worth noting that aKG-sensitive genes such as Tcf7 were not affected by DNA-methylation inhibitor treatment ( Figure 3D ). These data suggest that DNA methylation states play a context-dependent role in regulating the expression of a subset of IL-2-and aKG-sensitive genes.
A Subset of CTCF Sites Is Sensitive to IL-2 and aKG
The mechanisms that enable metabolic programs, which can influence broad changes in DNA and histone methylation states, to be translated into context-dependent gene programs are still being elucidated. CTCF has the capacity to influence the organization of the genome and plays a role in regulating developmental programs (Bonora et al., 2014) . Although many CTCF sites are constitutively occupied in diverse cell types, a subset of CTCF sites are occupied in a context-or cell-type sensitive manner in part related to the DNA methylation status of select CTCF sites in different cellular backgrounds (Fang et al., 2015; Ong and Corces, 2014) . A recent study found there was reduced association of CTCF with a subset of sites in glioma cells, which contained mutations in IDH that enhance 2-hydroxyglutarate (2HG) production (Flavahan et al., 2016) . 2HG competitively inhibits aKG-dependent activities and a recent study found that 2HG promotes the development of CD8 + memory T cells at the expense of effector cell differentiation (Tyrakis et al., 2016) . Taken together with our results, this leads to the hypothesis that aKG-sensitive metabolic states might influence CTCF activity to translate changes in IL-2-sensitive metabolism into new potentials for differentiation gene programs in T cells.
To begin to address this hypothesis, we performed a CTCF ChIP-seq analysis on CD4 + Th1 cells maintained in high IL-2, low IL-2, or low IL-2 with aKG to define the sites associated with CTCF in each condition. We first performed a clustering analysis of rank correlations using CTCF read depth across all identified binding sites to assess the relationship between the genomic localization of CTCF in each condition. CD4 + Th1 cells maintained in low IL-2 with aKG clustered more closely with the CD4 + Th1 cells in high IL-2 as compared to the low IL-2 condition ( Figure 4A ). These data indicated that CTCF association with genomic regions was more similar in cells maintained in high IL-2 and low IL-2 with aKG as compared to cells in the low IL-2 condition. We next performed a differential peak analysis comparing CTCF peaks in the Th1 cells maintained in either high IL-2 compared to the low IL-2 condition or low IL-2 with aKG compared to low IL-2. The vast majority of CTCF peaks from the ChIP-seq analysis were similarly enriched when comparing either high IL-2 relative to the low IL-2, or low IL-2 with aKG relative to the low IL-2 condition in Th1 cells. However, a subset of peaks, approximately 10%, displayed differential CTCF enrichment. There was a general increase in the frequency of peaks that had enhanced CTCF association in Th1 cells maintained in either high IL-2 or low IL-2 with aKG when compared relative to the low IL-2 condition ( Figure 4B ). These data suggest that IL-2-and aKG-sensitive events promote the association of CTCF with select sites across the genome.
A Subset of aKG-Sensitive Genes Is Associated with aKG-Sensitive CTCF Sites We next wanted to assess whether genes with aKG-sensitive expression in the RNA-seq analyses also had aKG-sensitive CTCF peaks in their vicinity. Approximately 40% of the genes with aKG-inducible gene expression were associated with aKG-inducible CTCF peaks in their proximity. Some examples of the aKG-inducible genes with aKG-sensitive CTCF peaks are shown in Figures 4C and S4A (also see Figures 5, 6A , 7, S4, S5, S6, and S7). aKG-inducible peaks were distributed across many different locations relative to the gene, including at distal sites upstream and downstream of the gene as well as in the promoter region. aKG-inducible CTCF peaks were often similarly induced in the high IL-2 condition ( Figures 4C, 5, 6A , 7, S4, S5, S6, and S7).
We next wanted to determine if CTCF plays a functional role in the expression of the genes that are located in proximity to IL-2-and aKG-sensitive CTCF peaks. To address this, we transfected primary CD4 + or CD8 + T cells polarizing in type 1 conditions with a control siRNA or an siRNA to Ctcf and maintained the cells in high IL-2. Reducing Ctcf mRNA using siRNAs caused a decrease in the expression of IL-2-and aKG-sensitive target genes as monitored by qRT-PCR ( Figure 4D , S4B, and S4C). In addition, we performed complementary experiments with an siRNA to Rad21, a member of the cohesin complex, which along with CTCF is important for chromatin loop formation. Reducing Rad21 expression using siRNAs also inhibited the expression of IL-2-and aKG-sensitive target genes ( Figures 4E and S4D ). These data suggest that CTCF complexes involved in genome organization play a role in the functional regulation of IL-2-and aKG-sensitive target gene expression.
IL-2-and aKG-Sensitive CTCF Binding Events Correlate with Changes in Genome Organization
Collectively, the ChIP-seq and siRNA data led to the hypothesis that IL-2-and aKG-sensitive CTCF binding events might influence genome organization. To address this, we performed an in situ Hi-C analysis on CD4 + Th1 cells maintained in high IL-2, low IL-2, or low IL-2 with aKG. After generating genomic contact matrices, we first performed a PC1 analysis to assess the composition of the open PC1 positive (permissive or transcriptionally active) and closed PC1 negative (inert or repressive) regions across the genome. We observed genomic regions that were differentially localized within open versus inert chromatin regions in an IL-2-and aKG-sensitive manner ( Figures 5A and  S5A ). For example, approximately 60 kb upstream and downstream of Lilrb4 was contained in an open configuration in primary Th1 cells maintained in either high IL-2 or low IL-2 with aKG conditions, whereas the region surrounding Lilrb4 was in an inert or closed configuration in the low IL-2 condition (Figure 5A ). There were IL-2-and aKG-sensitive CTCF sites flanking the boundaries delineating this change ( Figure 5A ), and the expression of Lilrb4 was induced by IL-2-, Gln-, and aKG-sensitive events in Th1 cells ( Figure 2L ). We also performed an analysis of the in situ Hi-C data to define the outer topological associated domain (TAD) boundaries. Changes in the organization of outer TAD boundaries were identified by IL-2-and aKG-sensitive CTCF sites in proximity to genes with IL-2-and aKG-sensitive expression. Examples included regions in proximity to Hk2 and Slc2a1, which were enhanced by IL-2-and aKG-sensitive events, and Cxcr3, which was inhibited by IL-2-and aKG-sensitive events ( Figures 5B and  S5B) . We also conducted an analysis of the in situ Hi-C data to determine the directionality index (DI) for genomic regions (Dixon et al., 2012) . A positive DI value indicates a bias for downstream interactions, whereas a negative DI value represents an interaction bias for upstream regions. In proximity to genes such as Hk2, Sell, and Slc2a1, the DI indicated that the interactions were predominantly in the same orientation (i.e., upstream or downstream) in Th1 cells maintained in high IL-2, low IL-2, or low IL-2 with aKG. However, the boundary changed or the strength of interaction bias was increased in the high IL-2 Figure 4C . (C and D) Circos plots for genomic regions surrounding Hlx (Chr1:184,000,000-187,200,000) and Cxcr4 (Chr1:128,800,000-131,040,000), indicating the probability for genomic interactions from the in situ Hi-C analysis. The minimum probability of interaction shown is a p value of % 0.0001, with the increased weight of a line indicating a higher significance for the interaction (lower p value).
(legend continued on next page) condition, as well as the low IL-2 with aKG condition, in comparison to the low IL-2 condition ( Figures S5 and S4F ). In addition, we observed several regions, including in proximity to Cxcr3, that showed similar DI configurations in the Th1 cells maintained in either high IL-2 concentrations or low IL-2 with aKG, whereas the region had an opposing directionality index in the low IL-2 condition ( Figure S5 ). Overall, roughly half of the genes that were induced by IL-2-, Gln-, and aKG-sensitive events were found in proximity to changes in chromatin topology.
Genomic Interactions Are Sensitive to IL-2 and aKG Events
We also performed interaction analyses to generate circos plots for genomic intervals surrounding select genes with IL-2-and aKG-sensitive expression to define the probabilities for interactions between specific genomic regions. The interaction analysis identified two pairs of genomic regions surrounding Hlx with a greater probability for the interaction in the high IL-2 and low IL-2 with aKG conditions as compared to the low IL-2 condition ( Figure 5C ). The interaction analysis also identified an enrichment of significant interactions (i.e., more interactions) in the genomic regions surrounding Hlx ( Figure 5C ). There were both IL-2-and aKG-sensitive changes in the probabilities for interactions and enrichment of significant interactions in the genomic regions by Cxcr4 and Prdm1, as well ( Figures 5D and S6A ). IL-2-and aKG-sensitive CTCF sites were often located in proximity to the genomic locations with increased probabilities of interactions ( Figures 5E and S6C) .
(E) UCSC genome browser tracks displaying CTCF ChIP-seq from Th1 cells exposed to high IL-2, low IL-2, or low IL-2 with aKG, and an ATAC-seq analysis of NP-specific CD8 + T cells isolated 9 days after influenza infection that were sorted into CD25 hi or CD25 lo populations. Regions displayed were associated with the interaction loops identified in the circos plots in (C) and (D). Blue arrows indicate IL-2-and aKG-sensitive CTCF sites, and yellow arrows indicate ATAC-seq changes. See also Figure S4 , S5, and S6. We next wanted to test the hypothesis that the genomic regions with increased probabilities of IL-2-and aKG-sensitive interactions might contain regulatory elements inside the interaction regions that were responsive to IL-2. In addition, we wanted to perform this analysis with T cells that were generated during a type 1 immune response in vivo to extend the mechanistic interpretations to T cells differentiating in their natural environment. To accomplish this, we performed an assay for transposaseaccessible chromatin-sequencing (ATAC-seq) experiments to define chromatin accessibility in antigen-specific CD8 + T cells generated during the course of an influenza infection in mice. The mechanistic prediction for these experiments was that the genomic interactions enhanced by IL-2-sensitive events would contain IL-2-sensitive regulatory elements (as monitored by differential chromatin accessibility) in CD25 hi relative to CD25 lo antigen-specific T cells. To examine this, we monitored ATAC-seq peaks found between CTCF sites and within the regions that were identified in the interaction analyses to have increased probabilities of IL-2-and aKG-sensitive interactions. We observed several examples in which there were regions with changes in accessibility in the CD25 hi compared to CD25 lo antigen-specific CD8 + T cells located within the IL-2-and aKG-sensitive interaction regions identified in the circos plots. These included regions adjacent to Hlx, Cxcr4, and Prdm1 ( Figures  5E and S6C ). In addition, there were ATAC-seq accessibility changes in the CD25 hi compared to CD25 lo antigen-specific CD8 + T cells in regions distant to Cxcr4, Prdm1, and Plk2 associated with enhanced IL-2-and aKG-sensitive interactions identified in the circos plots ( Figure S5C and S6).
IL-2-and aKG-Sensitive Changes in DNA Methylation at CTCF Peaks in Proximity to Hk2 and Sell
We next wanted to address whether IL-2-and aKG-sensitive modulation of CTCF association might relate to aKG-sensitive changes in DNA methylation. To start to test the role for DNA methylation in IL-2-and aKG-sensitive CTCF association, we performed bisulfite-sequencing experiments to monitor the methylation status of DNA sequences contained within the IL-2-and aKG-sensitive CTCF ChIP-seq enriched peaks. We monitored CTCF peaks that were associated with Hk2 and Sell, genes that were positively or negatively regulated by aKG-sensitive activities, respectively ( Figures 1A, 6A , S2A, and S2B). CpG sites within the IL-2-and aKG-sensitive CTCF enriched peaks found in proximity to Hk2 and Sell had less methylation in Th1 cells maintained in both high IL-2 or low IL-2 with aKG conditions in comparison to the low IL-2 condition ( Figure 6B , 6C, and S4E). Mechanistically consistent with our findings, a previous study showed that regions upstream of Sell reciprocally had enhanced methylation in 2HG-treated T cells (Tyrakis et al., 2016) . The IL-2-and aKG-sensitive decrease in DNA methylation correlated with IL-2-and aKGsensitive enhanced CTCF association, as well as alterations in genome organization in proximity to these regions ( Figures 6A,  S4F , and S5A). As noted above, inhibiting DNA methylation in primary CD4 + Th1 cells in low IL-2 conditions promoted Hk2 expression, while it inhibited Sell expression ( Figure 3D ). It is important to note that CpG sites associated with IL-2-and aKG-sensitive CTCF peaks were also found in regions with little methylation present in primary Th1 cells or with no differential methylation. This indicates that DNA methylation cannot be the only mechanism for IL-2-and aKG-sensitive targeting of CTCF. Further research will be necessary to define other aKG-sensitive mechanisms that contribute to modulating CTCF association with select sites in the genome. Taken together, the data suggest that IL-2-and aKG-sensitive inhibition of DNA methylation promotes the IL-2-and aKG-sensitive association of CTCF with a subset of genomic regions, and this correlates with changes in genomic topology. The IL-2-and aKG-sensitive events can be interpreted in a context-dependent manner as exemplified by the enhanced or diminished expression of Hk2 and Sell, respectively.
Context-Dependent Role for aKG-Sensitive CTCF Association
In IDH mutant gliomas that overproduce 2HG, a competitive inhibitor of aKG, there was hypermethylation at select CTCF sites that inhibited the binding of CTCF, including at a site contained within an insulator element that is upstream of the PDGFRA oncogene (Flavahan et al., 2016) . In Th1 cells, we observed aKG-sensitive association of CTCF with several sites surrounding the Pdgfra locus, and this correlated with an adjacent aKGsensitive change in genome organization ( Figure 7A ). Upon closer inspection of the identity of the genes in proximity to the IL-2-and aKG-sensitive CTCF peaks in Th1 cells, we further observed that many peaks were associated with genes expressed early in development, often in ES cells (Figures 7B and S7A) . This included CTCF sites within the HoxA locus and adjacent to Barx2 (Figures 7B and S7A ). In addition, there was an IL-2-and aKG-sensitive CTCF site associated with the Il17 locus ( Figure 7B ). Despite the aKG-sensitive induction of the CTCF peaks associated with the genes in these divergent developmental pathways, many of these genes were not expressed or only lowly expressed in Th1 cells.
Enhancer landscapes have been shown to be critical for defining both normal and pathogenic T cell differentiation programs (Vahedi et al., 2015; Vahedi et al., 2012) . In order for changes in CTCF binding events that influence genome organization to exert a functional outcome on gene expression, an active enhancer landscape would need to be present in that region. This creates a scenario where metabolically regulated changes in CTCF association and genome interactions might be interpreted in a cell-type-or context-dependent manner depending upon the enhancer landscape present. To start to address this hypothesis, we performed an H3K27Ac ChIP-seq analysis in Th1 cells maintained in high IL-2, low IL-2, or low IL-2 with aKG to examine potential enhancer regions in each condition. The IL-2-and aKG-sensitive effector genes in Th1 cells tended to contain regions of H3K27Ac in proximity to the genes that were actively expressed ( Figures 7B and S7B) . In some cases, the regions of H3K27Ac were both IL-2-and aKG-sensitive, whereas other regions of H3K27Ac were IL-2-sensitive, but not sensitive to aKG. In contrast, the genes from the divergent developmental pathways that were associated with aKG-sensitive CTCF peaks, but were not expressed in Th1 cells, tended to lack robust H3K27Ac in the regions surrounding the genes (Figures 7B and S7A) .
A Subset of Genes Associated with aKG-Sensitive CTCF Sites Is aKG-Sensitive in ES Cells This led us to ask whether the expression of a subset of genes associated with aKG-sensitive CTCF peaks might be induced by aKG in the context of a cell type where the genes are naturally expressed and presumably active enhancers are present. To address this, we performed qRT-PCR and RNA-seq analyses in the mouse ES cell line E14Tg2a that were either left untreated or exposed to aKG. Consistent with previous results in ES cells, Klf2 and Esrrb were downregulated by the addition of aKG, while Asz1 was upregulated as analyzed by qRT-PCR (data not shown) (Carey et al., 2015) . In the RNA-seq analysis, approximately one-third of the genes that were aKG-inducible in ES cells were associated with an aKG-inducible CTCF peak in Th1 cells. For example, the expression of Barx2, Pkp2, and several genes in the HoxA locus were induced by the addition of aKG to the ES cell line ( Figure 7C and data not shown). The RNA-seq analyses also identified a subset of genes that were aKG-sensitive in CD4 + Th1, CD8 + Tc1, and ES cells ( Figures 7C and S7C) . When comparing the aKG treatment to the untreated state in the different cell types, the relative fold induction for the genes was often similar between CD4 + Th1, CD8 + Tc1, and ES cells ( Figures 7C and S7C ). However, the absolute level of gene expression varied greatly between the T cells and ES cells. Collectively, the data are suggestive that aKG-sensitive metabolic events promote an initial mechanistic step, including enhancing CTCF binding at select sites, which is subsequently translated into consequences on gene expression in a contextdependent manner.
DISCUSSION
In this study, we identified a connection between IL-2-and aKGsensitive metabolic states with CTCF binding dynamics, genome organization, and gene programming events in CD4 + Th1 cells.
The data suggested that aKG-sensitive metabolic events are integrated by selective changes in CTCF genomic distribution, but this is interpreted in a context-dependent manner, which in part is influenced by the enhancer landscape in the cell. The finding that there is a connection between metabolites and CTCF association at select sites could help to explain how changes in metabolites that impact basic epigenetic processes might contribute to more specific gene programming events.
The observation that only a small fraction of CTCF sites display differential binding in response to aKG-induced metabolic changes creates the potential to focus general metabolic programming perturbations onto specific regions of the genome. Of note, because the interpretation of chromosomal organization events mediated by CTCF are directly influenced by both the epigenetic landscape and activities of the regulatory domains in the cell, the aKG-sensitive changes in CTCF association and genome organization will become context dependent. This provides a potential mechanistic interpretation for why each cell type did not have to evolve a novel way to interpret similar metabolic changes that occur during developmental transition states. It also might provide an explanation for how metabolic changes can both positively or negatively influence opposing gene programs in the same cell type. A recent study found that 2HG is important for the formation of memory T cells in vivo (Tyrakis et al., 2016) . 2HG is a competitive inhibitor of aKG, and predictable for this antagonistic metabolite pair, our experiments uncovered a role for aKG in promoting effector-associated gene expression and inhibiting memoryor Tfh-associated gene expression. Taken together, these independent and complementary studies indicate that the aKG-2HG metabolic axis is important for T cell differentiation. Future studies will need to define whether 2HG also antagonizes CTCF association with the genome in T cells, which would be predicted based upon the findings presented here and studies in glioma cells (Flavahan et al., 2016) . It will also be interesting to define whether disease states that overproduce 2HG and secrete it into the extracellular environment, such as in gliomas and AML with mutations in IDH, impact T cell function through modulating genome organization.
One area of caution in suggesting a direct connection between aKG-mediated events, such as DNA and histone demethylation, and the regulation of CTCF association, is that metabolic pathways are interconnected, making it difficult to definitively connect the change in the level of one metabolite with a specific downstream event. To mitigate the technical limitations of interpreting data associated with the addition of cell-permeable aKG to cells, we also performed experiments to limit Gln, which is one pathway that naturally produces intracellular aKG. Previous studies, as well as the data presented here, have shown that Gln is involved in effector T cell differentiation (Johnson et al., 2016; Nakaya et al., 2014; Wang et al., 2011) . This is at least in part because it regulates mTOR activity, which is involved in the regulation of a diverse set of genes (Finlay and Cantrell, 2011; Johnson et al., 2016; Nakaya et al., 2014) . In our study, the reciprocal activities associated with limiting Gln and rescuing activities with aKG were able to focus the analysis on the target genes that are the most likely to be naturally regulated by Gln-and aKG-sensitive activities. This allowed us to define a role for aKG-sensitive events in the role for Gln in T cell programming. However, because other metabolite activities are influenced by the glutaminolysis pathway as well, to be cautious in the interpretation of the data, we propose that the data are consistent with the interpretation that either aKG-dependent events, or events that are related to changes in aKG-sensitive metabolic programs, influence CTCF association with a subset of sites surrounding genes involved in cellular differentiation programs.
The data suggest that aKG activity in the context of TET enzymes plays a direct role in regulating IL-2-and aKG-sensitive CTCF association at a subset of sites. However, not all CTCF sites had differential methylation. Therefore, other activities must also play a role in targeting CTCF to a subset of genes. One possibility could be related to mTOR and hypoxia inducible factor 1 (HIF1) activities, and we observed an enrichment of genes in mTOR and HIF1-related pathways in the aKG-induced genes. However, we found that aKG was still able to induce or inhibit the expression of select IL-2-and aKG-sensitive genes in the presence of rapamycin, an mTOR inhibitor. Although this qRT-PCR analysis was not exhaustive, these data suggest that aKG-sensitive events are independent of mTOR in at least some circumstances. Further research is needed to address possible roles for other pathways to more comprehensively define the aKG-sensitive metabolic changes that are required for influencing CTCF binding. It will also be important to define other aKG-sensitive mechanistic steps that are independent of CTCF that regulate aspects of the IL-2-sensitive gene expression program.
IL-2 plays an important role in influencing T cell differentiation decisions, and the strength of IL-2-signaling impacts this selection process (Liao et al., 2013; Mitra et al., 2015; Spangler et al., 2015) . Our study now defined that metabolic changes sensitive to environmental IL-2 concentrations play a feed-forward role in influencing select aspects of differentiation programs in CD4 + Th1 and CD8 + Tc1 cells. In addition, we observed that IL-2 signaling enhanced the expression of some genes that encode the enzymes and transporters associated with the glutaminolysis pathway, and we speculate that this can serve in a positive feedback manner to promote the accumulation of metabolites, such as aKG. It is important to note that aKG-sensitive events only regulate a portion of the IL-2-sensitive program, and additional IL-2-sensitive events are often needed for full induction of gene expression. Therefore, taken together with the current data in the field, our study suggests that in addition to the role for IL-2 in regulating STAT proteins and other signaling pathways (Liao et al., 2013) , the ability of IL-2 to select metabolic states also influences its gene programming potential. Collectively, the findings now provide mechanistic links between TCR-and IL-2-sensitive metabolic state selection in T cells to gene programming decisions.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
METHOD DETAILS
Primary cell isolation and cell culture Primary CD4 + or CD8 + T cells were isolated from the spleen and lymph nodes of at least 6 week old C57BL/6 mice using negative selection MagCellect kits (R&D systems) as described in previous publications (Oestreich et al., 2012; Oestreich et al., 2014) . Cells were stimulated with plate-bound anti-CD3 (clone 145-2C11, 5 mg/mL) and anti-CD28 (clone 37.51, 10 mg/mL) and polarized in type 1 conditions (anti-IL4 (clone 11B11, 10 mg/mL) and IL-12 (R&D catalog number 419ML-010, 5ng/mL)). At day 3, cells were split and cultured for two days in the presence of either high IL-2 (100units/mL), high IL-2 with DON (6-Diazo-5-oxo-L-norleucine Sigma, D2141, 0.5ug/mL), high IL-2 with GSK-J4 (Millipore, histone lysine demethylase inhibitor VIII GSK-J4 CAS 1373423-53-0, 5 mM), low IL-2 (2.5units/mL), low IL-2 with cell permeable aKG (dimethyl-alpha-ketoglutarate, Sigma 349631, 4mM), low IL-2 with cell permeable succinate (dimethyl-succinate, Sigma W239607, 4mM), low IL-2 with 5-azacytidine (Sigma, A1287, 5uM), low IL-2 with rapamycin (EMD Millipore; 553211, 200nM), or low IL-2 with rapamycin and cell permeable aKG. Working concentrations of cell permeable aKG and succinate used in cell culture were determined from a published study (Carey et al., 2015) . Experiments with mice were performed with approval from the University of Alabama at Birmingham IACUC.
For the experiments to define the role for glutamine in the IL-2-senstive programming of Th1 cells, primary CD4 + T cells were isolated and stimulated with plate bound aCD3 (5 mg/mL) and aCD28 (10 mg/mL) in either IMDM (Life Technologies) or RPMI without glutamine (Life Technologies) media in type 1 polarizing conditions. At day three, the cells were split into RPMI media either with or without glutamine (Life Technologies) and maintained in high IL-2, high IL-2 with aKG (4mM), low IL-2, or low IL-2 with aKG (4mM) for two days. IMDM or RPMI medias contained 10% FBS (Life Technologies), 1% Penicillin/Streptomycin (Life Technologies), and 50 mM 2-mercaptoethanol (Sigma). The ES cell line E14TG2a (generously supplied by Hao Jiang (UAB)) was maintained in DMEM knockout media (Life Tecnhologies) with 15% ES cell certified FBS (Omega Scientific), 0.1mM non-essential amino acids (Life Technologies), 2mM glutamine (Life Technologies), 0.1mM 2-mercaptoethanol (Sigma), and 1000units/mL of recombinant LIF (Biolegend) grown on 0.1% gelatin (Millipore) coated plates. For experiments, the cells were exposed to this media without glutamine and either left untreated or treated with cell permeable aKG for two days as previously described (Carey et al., 2015) .
Quantitative RT-PCR RNA was isolated from the cells using the Nucleospin RNA kit (Clontech). cDNA was made using the PrimeScript first strand cDNA synthesis kit (Clontech). An equal amount of cDNA was amplified with the iQSybr Green Mix (Biorad) using gene specific primers. See quantification and statistical analysis section for details on data analysis.
RNA-sequencing (RNA-seq) and analysis At least 2 (CD4 + T cells without glutamine at time of TCR activation), 3 (all other CD4 + Th1 cells) or 4 (CD8 + Tc1 cells and ES cells) independent biological replicate experiments for each condition were analyzed with RNA-seq. Library preparation and RNA sequencing was conducted through Genewiz. Libraries were sequenced using a 1x50bp single end rapid run on the HiSeq2500 platform. The analysis of the RNA-seq data was performed using the Penn State Galaxy publicly available server using the Tuxedo suite analysis tools. Fastq files were first aligned to the mm10 reference genome using Tophat (Kim et al., 2013) . Cufflinks, Cuffmerge, Cuffquant, and Cuffnorm were performed to define FPKM values for genes (Trapnell et al., 2010) . Differential gene expression was determined using Cuffdiff (Trapnell et al., 2010) . For the Venn Diagrams, proportional graphical representations were made with the BioVenn program (Hulsen et al., 2008) . All statistically significant genes with at least a 2-fold change and FPKM value of 1 or greater in at least one condition were included in differential gene analyses. For Figure 2L , genes were initially identified in a CuffDiff analysis based upon statistically significant differences with at least a 2-fold change between the Th1 cells continuously maintained with glutamine in high IL-2 compared to Th1 cells continuously maintained without glutamine in high IL-2. The genes also have at least a 2-fold change in the Th1 cells continuously maintained with glutamine in the high IL-2 versus the low IL-2 comparison, and the low IL-2 with aKG versus the low IL-2 comparison. Heatmaps were generated using the gplots package (version 3.0.1) into R version 3.3.1. The final six genes displayed in the heatmap for the inhibited genes used a fold change cutoff of 1.8.
Gene Set Enrichment Analysis (GSEA) GSEA was performed using the Molecular Signatures Database on the publicly available MIT BROAD Institute server (Subramanian et al., 2005) . The genes analyzed by GSEA were generated from the Cuffdiff analysis of the RNA-seq experiments from CD4 + Th1 cells, CD8 + Tc1 cells, or ES cells. The differential expressed gene datasets used were derived from the genes identified as statistically significant in the Cuffdiff analysis that also had at least a 2-fold change and an FPKM expression value of 1 in at least one of the conditions.
Proliferation Assay
Upon isolation, 2.5x10 6 primary CD4 + T cells were labeled with cell proliferation dye 450 (eBiosciences). Briefly cells were washed two times with PBS (Life Technologies) and stained in 1X dye in a 2.0 3 10 7 concentration for 20 min at room temperature in the dark. The reaction was quenched by adding 5X IMDM media (Life Technologies), and incubated on ice for 5 min in the dark. Cells were washed twice with media, and plated at a concentration of 0.6x10 6 cells and cultured as described above for activation and polarization. On day 3, cells were split and cultured as described above. On day 5, 1x10 6 cells were additionally stained with CD4 (GK1.5, Biolgend) and analyzed by flow cytometry.
Transfection of primary CD4
+ Th1 or CD8 + Tc1 cells Primary CD4 + or CD8 + T cells were isolated from C57BL/6 mice and stimulated on plates coated with aCD3 (5 mg/mL) and aCD28
UCSC genome browser
ChIP-seq, ATAC-seq, and Hi-C data are displayed using the University of California Santa Cruz (UCSC) genome browser (http:// genome.ucsc.edu/) (Kent et al., 2002) .
QUANTIFICATION AND STATISTICAL ANALYSIS
For qRT-PCR, the Rps18 gene was used for normalization of each sample. Normalized samples were then compared relative to the low IL-2 condition ( Figure 1A, 1B, 3D ), high IL-2 with glutamine ( Figure 2F ), high IL-2 ( Figure 3C ) or control siGFP ( Figures 4D and 4E ) sample for each independent experiment. Statistical analysis for qRT-PCR: the error bars represent standard error mean (SEM). Unpaired Student's t tests were conducted using the GraphPad Prism online software. For the influenza experiments, the data are shown as the mean ± SD (n = 5-6 mice/group) and are representative of two independent experiments. A two-tailed Student's t test was used to analyze the data and determine the p value. RNA-seq analysis and statistics were performed using the Tuxedo suite tools with the Penn State Galaxy website. Quantification and alignments of NGS analysis for RNA-seq, ChIP-seq and ATAC-seq are also described in more detail in the methods section above.
DATA AND SOFTWARE AVAILABILITY
All of the sequencing data can be found publicly available on the NCBI GEO website under the accession number for a Super Series GEO: GSE89722. The accession number for the individual sequencing types are as follows: RNA-seq: GEO: GSE88829; ChIP-seq: GEO: GSE88857; ATAC-seq: GEO: GSE89038; and HiC-Seq: GEO: GSE89676.
